These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17187022)

  • 1. Reduced hypothalamic gray matter in narcolepsy with cataplexy.
    Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S
    Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel-based morphometry in hypocretin-deficient narcolepsy.
    Overeem S; Steens SC; Good CD; Ferrari MD; Mignot E; Frackowiak RS; van Buchem MA; Lammers GJ
    Sleep; 2003 Feb; 26(1):44-6. PubMed ID: 12627731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxel-based morphometry in narcolepsy.
    Brenneis C; Brandauer E; Frauscher B; Schocke M; Trieb T; Poewe W; Högl B
    Sleep Med; 2005 Nov; 6(6):531-6. PubMed ID: 15994127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray matter deficits in young adults with narcolepsy.
    Kim SJ; Lyoo IK; Lee YS; Lee JY; Yoon SJ; Kim JE; Kim JH; Hong SJ; Jeong DU
    Acta Neurol Scand; 2009 Jan; 119(1):61-7. PubMed ID: 18624787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons.
    Knudsen S; Mikkelsen JD; Jennum P
    Neuroreport; 2007 Jan; 18(1):77-9. PubMed ID: 17259865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.
    Tonon C; Franceschini C; Testa C; Manners DN; Poli F; Mostacci B; Mignot E; Montagna P; Barbiroli B; Lodi R; Plazzi G
    Brain Res Bull; 2009 Sep; 80(3):147-50. PubMed ID: 19463917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy.
    Overeem S; Verschuuren JJ; Fronczek R; Schreurs L; den Hertog H; Hegeman-Kleinn IM; van Duinen SG; Unmehopa UA; Swaab DF; Lammers GJ
    J Neuroimmunol; 2006 May; 174(1-2):187-91. PubMed ID: 16563524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy.
    Menzler K; Belke M; Unger MM; Ohletz T; Keil B; Heverhagen JT; Rosenow F; Mayer G; Oertel WH; Möller JC; Knake S
    Sleep Med; 2012 Jun; 13(6):736-42. PubMed ID: 22541810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
    Thannickal TC; Nienhuis R; Siegel JM
    Sleep; 2009 Aug; 32(8):993-8. PubMed ID: 19725250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical morphometry in narcolepsy with cataplexy.
    Schaer M; Poryazova R; Schwartz S; Bassetti CL; Baumann CR
    J Sleep Res; 2012 Oct; 21(5):487-94. PubMed ID: 22309460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).
    Baier PC; Weinhold SL; Huth V; Gottwald B; Ferstl R; Hinze-Selch D
    Brain; 2008 Oct; 131(Pt 10):2734-41. PubMed ID: 18718966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome.
    Fronczek R; Lammers GJ; Balesar R; Unmehopa UA; Swaab DF
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5466-70. PubMed ID: 15985489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic gray matter changes in narcoleptic patients.
    Draganski B; Geisler P; Hajak G; Schuierer G; Bogdahn U; Winkler J; May A
    Nat Med; 2002 Nov; 8(11):1186-8. PubMed ID: 12411926
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.
    Black JL; Silber MH; Krahn LE; Avula RK; Walker DL; Pankratz VS; Fredrickson PA; Slocumb NL
    Biol Psychiatry; 2005 Sep; 58(6):504-9. PubMed ID: 16043129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy.
    Dauvilliers Y; Bauer J; Rigau V; Lalloyer N; Labauge P; Carlander B; Liblau R; Peyron C; Lassmann H
    JAMA Neurol; 2013 Oct; 70(10):1305-10. PubMed ID: 23939463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression.
    Allard JS; Tizabi Y; Shaffery JP; Trouth CO; Manaye K
    Neuropeptides; 2004 Oct; 38(5):311-5. PubMed ID: 15464197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy.
    Honda M; Arai T; Fukazawa M; Honda Y; Tsuchiya K; Salehi A; Akiyama H; Mignot E
    Neurology; 2009 Aug; 73(7):511-7. PubMed ID: 19687452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.